BackStrongbridge Biopharma plc Overview

Strongbridge Biopharma plc Other Assets

Strongbridge Biopharma plc's other assets is $0.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average

Loading

Strongbridge Biopharma plc Other Assets History

Loading

Strongbridge Biopharma plc vs. peers: Other Assets Comparison

Loading

Strongbridge Biopharma plc Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Strongbridge Biopharma plc (SBBP) FAQ

Strongbridge Biopharma plc (SBBP) currently reports a other assets of $0 as of June 2021. In the prior-year period, the figure was $0. Use the charts on this page to explore Strongbridge Biopharma plc's other assets history and peer comparisons.

Strongbridge Biopharma plc's other assets changed from $0 to $0 (period ending June 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Strongbridge Biopharma plc reported $0 in other assets as of June 2021. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Strongbridge Biopharma plc, and consider following SBBP for alerts when major investors trade the stock.

Strongbridge Biopharma plc is classified in the Healthcare sector. On other assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SBBP with unrelated industries.